Homeostatic erythropoiesis by the transcription factor IRF2 through attenuation of type I interferon signaling

Experimental Hematology

Volumn 36, Issue 3, 2008, Pages 255-264

  Mizutani, Tatsuaki ^a   Tsuji, Kohichiro ^b   Ebihara, Yasuhiro ^b   Taki, Shinsuke ^c   Ohba, Yusuke ^a   Taniguchi, Tadatsugu ^a   Honda, Kenya ^a,d  

^a GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; ERYTHROPOIETIN; INTERFERON; INTERFERON ALPHA RECEPTOR 1; INTERFERON REGULATORY FACTOR 2; PROTEIN BCL XL; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; BONE MARROW; CELL COUNT; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DYSERYTHROPOIESIS; ERYTHROBLAST; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; GENE FUNCTION; GENE MUTATION; HEMOSTASIS; HOMOZYGOSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANEMIA, APLASTIC; ANIMALS; APOPTOSIS; BCL-X PROTEIN; BONE MARROW; CELL COUNT; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; ERYTHROBLASTS; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HEMATOLOGIC TESTS; INTERFERON REGULATORY FACTOR-2; INTERFERON TYPE I; MICE; MICE, KNOCKOUT; MUTATION; RECEPTOR, INTERFERON ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MUS;

EID: 39149135837     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.11.004     Document Type: Article

References (33)

1. Watowich S.S., Wu H., Socolovsky M., Klingmuller U., Constantinescu S.N., and Lodish H.F. Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu Rev Cell Dev Biol 12 (1996) 91-128
2. Koury M.J., and Bondurant M.C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248 (1990) 378-381
3. Kelley L.L., Koury M.J., Bondurant M.C., Koury S.T., Sawyer S.T., and Wickrema A. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 82 (1993) 2340-2352
4. Wu H., Liu X., Jaenisch R., and Lodish H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83 (1995) 59-67
5. Ingley E., Tilbrook P.A., and Klinken S.P. New insights into the regulation of erythroid cells. IUBMB Life 56 (2004) 177-184
6. Koury M.J. Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone. Exp Hematol 33 (2005) 1263-1270
7. Witthuhn B.A., Quelle F.W., Silvennoinen O., et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74 (1993) 227-236
8. Socolovsky M., Fallon A.E., Wang S., Brugnara C., and Lodish H.F. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98 (1999) 181-191
9. Yoshimura A., Ichihara M., Kinjyo I., et al. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J 15 (1996) 1055-1063
10. Pircher T.J., Zhao S., Geiger J.N., Joneja B., and Wojchowski D.M. Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death. Oncogene 19 (2000) 3684-3692
11. Socolovsky M., Nam H., Fleming M.D., Haase V.H., Brugnara C., and Lodish H.F. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98 (2001) 3261-3273
12. Menon M.P., Karur V., Bogacheva O., Bogachev O., Cuetara B., and Wojchowski D.M. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. J Clin Invest 116 (2006) 683-694
13. Taniguchi T., Ogasawara K., Takaoka A., and Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19 (2001) 623-655
14. Honda K., Takaoka A., and Taniguchi T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25 (2006) 349-360
15. Honda K., and Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6 (2006) 644-658
16. Hida S., Ogasawara K., Sato K., et al. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 13 (2000) 643-655
17. Takaoka A., Mitani Y., Suemori H., et al. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 288 (2000) 2357-2360
18. Honda K., Mizutani T., and Taniguchi T. Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells. Proc Natl Acad Sci U S A 101 (2004) 2416-2421
19. Ichikawa E., Hida S., Omatsu Y., et al. Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2. Proc Natl Acad Sci U S A 101 (2004) 3909-3914
20. Matsuyama T., Kimura T., Kitagawa M., et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75 (1993) 83-97
21. Rhodes M.M., Kopsombut P., Bondurant M.C., Price J.O., and Koury M.J. Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin. Blood 106 (2005) 1857-1863
22. Wagner K.U., Claudio E., Rucker III E.B., et al. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development 127 (2000) 4949-4958
23. Ingley E., McCarthy D.J., Pore J.R., et al. Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis. Oncogene 24 (2005) 336-343
24. Cartwright G.E. The anemia of chronic disorders. Semin Hematol 3 (1966) 351-375
25. Macdougall I.C., and Cooper A.C. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 17 Suppl 11 (2002) 39-43
26. Ganz T. Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer 46 (2006) 554-557
27. Goodnough L.T. Erythropoietin and iron-restricted erythropoiesis. Exp Hematol 35 (2007) 167-172
28. Zoumbos N.C., Djeu J.Y., and Young N.S. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 133 (1984) 769-774
29. Broxmeyer H.E., Williams D.E., Lu L., et al. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol 136 (1986) 4487-4495
30. Frede S., Fandrey J., Pagel H., Hellwig T., and Jelkmann W. Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats. Am J Physiol 273 (1997) R1067-R1071
31. Thawani N., Tam M., Chang K.H., and Stevenson M.M. Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo. Exp Hematol 34 (2006) 1451-1461
32. Kato K., Kamezaki K., Shimoda K., et al. Intracellular signal transduction of interferon on the suppression of haematopoietic progenitor cell growth. Br J Haematol 123 (2003) 528-535
33. Vilcek J. Fifty years of interferon research: aiming at a moving target. Immunity 25 (2006) 343-348